Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To The Board of Directors

Skystar Bio-Pharmaceutical Company

We consent to the use of our report dated March 31, 2008 on the consolidated financial statements of Skystar Bio-Pharmaceutical Company as of December 31, 2007 and for the years ended December 31, 2007 and 2006, included herein on the amended registration statement of Skystar Bio-Pharmaceutical Company on Form S-1 Amendment No. 3, and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ Moore Stephens Wurth Frazer and Torbet, LLP

Moore Stephens Wurth Frazer and Torbet, LLP

Walnut, California

August 21, 2008